Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Lung Neoplasms 22Breast Neoplasms 18Hematologic Neoplasms 16Colorectal Neoplasms 13Prostatic Neoplasms 11Neoplasms 10Carcinoma, Non-Small-Cell Lung 10Pancreatic Neoplasms 9Hematopoietic and Lymphatic System Neoplasm 9Anatomic Stage I Breast Cancer AJCC v8 9Urinary Bladder Neoplasms 6Ovarian Neoplasms 6Neoplasm Metastasis 6Uterine Cervical Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Multiple Myeloma 5Leukemia, Myeloid, Acute 5Head and Neck Carcinoma 5Breast Carcinoma In Situ 5Triple Negative Breast Neoplasms 4Stomach Neoplasms 4Melanoma 4Hematopoietic and Lymphoid System Neoplasm 4Head and Neck Neoplasms 4Carcinoma, Renal Cell 4Rectal Neoplasms 3Myelodysplastic Syndromes 3Mouth Neoplasms 3Malignant Solid Neoplasm 3Lymphoma 3

Interventions

entecavir 9Tenofovir 3Lamivudine 3lenvatinib 2Sorafenib 2Hepatitis B Vaccines 2tenofovir alafenamide 1polysaccharide MGN3 1peginterferon alfa-2b 1navitoclax 1menatetrenone 1lens intermediate filament proteins 1human papillomavirus vaccine, L1 type 16, 18 1adefovir 1Ultrasonography 1Tumor Necrosis Factor-alpha 1Tetanus Toxoid 1Telbivudine 1Standard of Care 1Rapid Diagnostic Tests 1Raltegravir Potassium 1Radiofrequency Ablation 1Practice Guidelines as Topic 1Polymorphism, Genetic 1Pneumococcal Vaccines 1PHY 906 1Nivolumab 1Measles-Mumps-Rubella Vaccine 1Hypothermia, Induced 1Heptavalent Pneumococcal Conjugate Vaccine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Hepatitis B × Practice Guidelines as Topic × Clear all
NCT03887702 2024-05-20

Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors

SWOG Cancer Research Network

Phase 3 Terminated
4 enrolled 5 charts

Hepatitis B

Data powered by HemOnc (CC BY 4.0) Colophon âš¡